Heat Shock Proteins Promote Cancer: It's a Protection Racket.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  TIBS -Trends in Biochemical Sciences. Regular ed

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tibs.2016.01.003PMID 26874923PMCID PMC4911230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.

  2016cited by this paper
• Tumor-secreted Hsp90 Subverts Polycomb Function to Drive Prostate Tumor Growth and Invasion*

  2015cited by this paper
• Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec‐5 and Siglec‐14

  2015cited by this paper
• Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis

  2015influential reference
• Chaperonin-Assisted Protein Folding: Relative Population of Asymmetric and Symmetric GroEL:GroES Complexes.

  2015cited by this paper
• Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery

  2015cited by this paper
• The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes.

  2015cited by this paper
• Sugar? No Thank You, Just a Deep Breath of Oxygen for Cancer Stem Cells.

  2015cited by this paper
• Cancer stem cells: the promise and the potential.

  2015influential reference
• Pathways of allosteric regulation in Hsp70 chaperones

  2015cited by this paper
• HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells

  2015cited by this paper
• Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines

  2015cited by this paper
• Hsp90&agr; and Hsp90&bgr; together operate a hypoxia and nutrient paucity stress‐response mechanism during wound healing

  2015cited by this paper
• DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

  2015cited by this paper
• Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation

  2015cited by this paper
• Immense Cellular Implications Associated to Small Stress Proteins Expression: Impacts on Human Pathologies

  2015cited by this paper
• Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.

  2015cited by this paper
• HSF1 REGULATION OF β-CATENIN IN MAMMARY CANCER CELLS THROUGH CONTROL OF HUR / ELAVL1 EXPRESSION

  2014cited by this paper
• TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLC

  2014cited by this paper
• Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles.

  2014cited by this paper
• MMP9 Processing of HSPB1 Regulates Tumor Progression

  2014cited by this paper
• MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.

  2014influential reference
• Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation

  2014cited by this paper
• Hsp70-Bag3 interactions regulate cancer-related signaling networks.

  2014influential reference
• RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

  2014cited by this paper
• The co‐chaperone p23 promotes prostate cancer motility and metastasis

  2014cited by this paper
• Modulation of the Hsp90 chaperone cycle by a stringent client protein.

  2014cited by this paper
• Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

  2014cited by this paper
• Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer

  2014cited by this paper
• HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor

  2014cited by this paper
• HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models

  2014cited by this paper
• Hsp70 in cancer: back to the future

  2014cited by this paper
• Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis

  2013cited by this paper
• Molecular Cochaperones: Tumor Growth and Cancer Treatment

  2013cited by this paper
• Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.

  2013cited by this paper
• Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3

  2013influential reference
• Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: Potent targets for cancer stem cell therapy

  2013cited by this paper
• Immunotherapy of Radioresistant Mammary Tumors with Early Metastasis Using Molecular Chaperone Vaccines Combined with Ionizing Radiation

  2013cited by this paper
• The Oncogene HER2/neu (ERBB2) Requires the Hypoxia-inducible Factor HIF-1 for Mammary Tumor Growth and Anoikis Resistance*

  2013cited by this paper
• The small heat shock protein Hsp27 affects assembly dynamics and structure of keratin intermediate filament networks.

  2013cited by this paper
• The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models.

  2013cited by this paper
• Aging, cellular senescence, and cancer.

  2013cited by this paper
• Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer.

  2013cited by this paper
• Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy.

  2013cited by this paper
• Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.

  2013cited by this paper
• The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease

  2013cited by this paper
• 17-AAG mediated targeting of Hsp90 limits tert activity in peritoneal sarcoma related malignant ascites by downregulating cyclin D1 during cell cycle entry.

  2012cited by this paper
• The heat shock transcription factor Hsf1 is downregulated in DNA damage–associated senescence, contributing to the maintenance of senescence phenotype

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Extracellular HSP27 acts as a signaling molecule to activate NF-κB in macrophages

  2012cited by this paper
• Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update

  2012cited by this paper
• HspB1 dynamic phospho-oligomeric structure dependent interactome as cancer therapeutic target.

  2012cited by this paper
• Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers

  2012cited by this paper
• Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo

  2012cited by this paper
• Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

  2012cited by this paper
• HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.

  2012cited by this paper
• Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2

  2012cited by this paper
• N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence

  2012cited by this paper
• Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer*

  2012cited by this paper
• Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform.

  2012cited by this paper
• Hsp70 protein levels and thermotolerance in Drosophila subobscura: a reassessment of the thermal co‐adaptation hypothesis

  2012cited by this paper
• Post-translational modifications of Hsp90 and their contributions to chaperone regulation.

  2012cited by this paper
• Structure and dynamics of the ATP-bound open conformation of Hsp70 chaperones.

  2012cited by this paper
• Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity

  2011cited by this paper
• Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.

  2011cited by this paper
• Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB

  2011cited by this paper
• Heat shock proteins

  2011cited by this paper
• Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011influential reference
• Gastric cancer in individuals with Li-Fraumeni syndrome

  2011cited by this paper
• Heat shock factors: integrators of cell stress, development and lifespan

  2010cited by this paper
• Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

  2010cited by this paper
• The heat shock response: life on the verge of death.

  2010cited by this paper
• Dynamic processes that reflect anti-apoptotic strategies set up by HspB1 (Hsp27).

  2010cited by this paper
• Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene

  2009cited by this paper
• Impact of heat-shock protein 90 on cancer metastasis.

  2009influential reference
• Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells

  2008influential reference
• Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.

  2008cited by this paper
• Targeting the oncogene and kinome chaperone CDC37

  2008cited by this paper
• Apoptosis Versus Cell Differentiation

  2007cited by this paper
• Protein misassembly: macromolecular crowding and molecular chaperones.

  2007cited by this paper
• High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways.

  2007cited by this paper
• Role of Heat Shock Proteins HSP90, HSP70 and HSP27

  2007cited by this paper
• Hsp27 modulates p53 signaling and suppresses cellular senescence.

  2007cited by this paper
• The Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities

  2007cited by this paper
• Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer.

  2007cited by this paper
• Heat shock proteins in cancer: chaperones of tumorigenesis.

  2006cited by this paper
• Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties

  2006cited by this paper
• Heat Shock Protein 70 Is Secreted from Tumor Cells by a Nonclassical Pathway Involving Lysosomal Endosomes1

  2006cited by this paper
• Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications

  2005cited by this paper
• Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells

  2005cited by this paper
• Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo

  2005cited by this paper
• Induction of heat shock proteins by heregulin β1 leads to protection from apoptosis and anchorage-independent growth

  2005cited by this paper
• Heat Shock Protein 90 Stabilization of ErbB2 Expression Is Disrupted by ATP Depletion in Myocytes*

  2005cited by this paper
• HSP110-HER2/neuChaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice

  2003cited by this paper
• Decreased Expression of the DNA Mismatch Repair Gene Mlh1 under Hypoxic Stress in Mammalian Cells

  2003cited by this paper
• HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice 1

  2003cited by this paper
• Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance.

  2003cited by this paper
• A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

  2003cited by this paper
• Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome

  2000influential reference

• Multifunctional Tumor-Specific Carrier-Free Nanodrugs for Triple-Negative Breast Cancer Treatment by Combination of Chemotherapy, PTT, and Immunotherapy.

  2026cites this paper
• Oxidative Stress and Its Role in Vascular Damage and Atherosclerosis

  2026cites this paper
• Phenethyl isothiocyanate ameliorates liver injuries secondary to inflammatory bowel disease.

  2025cites this paper
• HSP47 inhibition-induced CD155 expression through TRAF2 deubiquitination promotes tumor immune evasion

  2025cites this paper
• RhoA functionally collaborates with HSPA1A to promote the migratory phenotype of cancer cells.

  2025cites this paper
• From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy

  2025cites this paper
• Spatially Resolved Molecular Investigation of Perineural Invasion in Lacrimal Gland Adenoid Cystic Carcinoma.

  2025cites this paper
• Development of Theranostic 177Lu-Labeled Polymeric Nanoparticles (177Lu-PNPs) for the Treatment of Head and Neck Cancer

  2025cites this paper
• Decoding the Crosstalk Between Heat Shock Proteins and Phytochemicals in Thyroid Nodule Regression: Mechanisms and Therapeutic Implications

  2025cites this paper
• Structural and functional impact of the p.R163C mutation in the conserved palindromic motif within the C-terminal domain of human αB-crystallin

  2025cites this paper
• Heat Preconditioning of Nanofat Does Not Improve Its Vascularization Properties

  2025cites this paper
• A Pd nanoparticle-loaded nanoscale covalent organic framework to enhance tumor therapy by synergistic hydrogen/photothermal therapy.

  2025cites this paper
• Mechanisms and applications of mitochondrial chaperone inhibitors

  2025cites this paper
• Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling

  2025cites this paper
• The relationship between KSHV and the cellular DNA damage response

  2025cites this paper
• Unravelling the p53 misfolding by chaperones in cancer.

  2025cites this paper
• NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy

  2025cites this paper
• Virtual screening of polyherbal compounds for AKT1 and HSPB1 inhibition in breast cancer apoptosis pathway

  2025cites this paper
• Orthogonal programmed tri-modal tumor treatment based on structurally simple nanomedicines.

  2025cites this paper
• Hematopoietic stem cell conditioned media induces apoptosis in colorectal cancer stem cells via dysregulation of HSP90 and 26S proteasome system.

  2025cites this paper
• The role of heat shock proteins in tumorigenesis and their potential as targets for anti-tumor therapy.

  2025cites this paper
• Heat shock protein 70 (Hsp70) as a target for advancing immunotherapy in solid tumors.

  2025cites this paper
• Structural Control for Tunable Hyperthermia-Induced Cellular Responses Using 3D-Printed Platforms

  2025cites this paper
• HSP90B1 facilitates glioma radiotherapy resistance by regulating RhoC ubiquitin‒proteasome degradation.

  2025cites this paper
• Heat shock protein D1 is up-regulated in various types of canine mammary tumors

  2025cites this paper
• G4 Oligonucleotide-Based Chaperones of Heterogeneous Nuclear Ribonucleoprotein A1

  2025cites this paper
• Comprehensive analysis of heat shock proteins in glioma revealed the association with glioma-associated myeloid cells

  2025cites this paper
• Heat shock proteins (HSPs) as chaperones for oncogenesis.

  2025cites this paper
• Small molecule modulators of TOX protein re-invigorate T cell activity

  2025cites this paper
• Advances in the structures, mechanisms and targeting of molecular chaperones

  2025cites this paper
• Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents?

  2025cites this paper
• Targeting HSP70 protein-protein interactions for cancer precision Therapy: Mechanisms, structures, and inhibitor strategies.

  2025cites this paper
• Covalent organic frameworks: Prospects and potential in tumor diagnosis and therapy

  2025cites this paper
• PiRNAs, PiRNA‐Like, and PIWI Proteins in Somatic Cells: From Genetic Regulation to Disease Mechanisms

  2025cites this paper
• Identification and biological evaluation of fused tetrahydroisoquinoline derivatives as Wnt/β-catenin signaling inhibitors to suppress colorectal cancer.

  2024cites this paper
• Membrane-bound Heat Shock Protein mHsp70 Is Required for Migration and Invasion of Brain Tumors

  2024cites this paper
• Diagnosis and treatment status of inoperable locally advanced breast cancer and the application value of inorganic nanomaterials

  2024cites this paper
• Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches

  2024cites this paper
• Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells

  2024cites this paper
• Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives

  2024influential citation
• Preclinical Verification of Modulated Electro-Hyperthermia—Part III. Immunogenic Effects

  2024cites this paper
• The Multiple Roles of Heat Shock Proteins in the Development of Inflammatory Bowel Disease.

  2024cites this paper
• Anticarcinogenic Effects of Gold Nanoparticles and Metformin Against MCF-7 and A549 Cells

  2024cites this paper
• Construction of a 12-gene prognostic model for colorectal cancer based on heat shock protein-related genes

  2024cites this paper
• Caffeic acid phenethyl ester mediates apoptosis in serum‐starved HT29 colon cancer cells through modulation of heat shock proteins and MAPK pathways

  2024cites this paper
• Modulation of Heat Shock Protein Expression in Alveolar Adenocarcinoma Cells through Gold Nanoparticles and Cisplatin Treatment

  2024cites this paper
• Exploring Mutation-Driven Changes in the ATP-ADP Conformational Cycle of Human Hsp70 by All-Atom MD Adaptive Sampling.

  2024cites this paper
• The advancement of siRNA-based nanomedicine for tumor therapy.

  2024cites this paper
• Regulating Aggregation‐Induced Emission Luminogen for Multimodal Imaging‐Navigated Synergistic Therapy Involving Anti‐Angiogenesis

  2024cites this paper
• MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis.

  2024cites this paper
• Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer.

  2024cites this paper
• Development of a novel N14-substituted antitumor evodiamine derivative with inhibiting heat shock protein 70 in non-small cell lung cancer

  2024cites this paper
• Role of heat shock protein 70 in silibinin-induced apoptosis in bladder cancer

  2024cites this paper
• Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies

  2024cites this paper
• Soluble markers of viral rebound and post-treatment HIV control

  2024cites this paper
• HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling

  2024cites this paper
• Chaperones vs. oxidative stress in the pathobiology of ischemic stroke

  2024cites this paper
• A Brief Review on Foeniculum Vulgare Mill Highlighting Gastroprotective Activity

  2024cites this paper
• Research progress of exosome biosensors

  2023cites this paper
• Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells

  2023cites this paper
• Relationship between intrathrombotic appearance of HSP27 and HSP70 and thrombus ages in a murine model of deep vein thrombosis

  2023cites this paper
• The pathogenicity and immune effects of different generations of Mycoplasma synoviae on chicken embryos

  2023cites this paper
• Reevaluating the Concept of Aging: Long-Term Stress Adaptation as a Key Factor in Yeast Aging

  2023cites this paper
• Nanotechnology Potent Photothermal and Photodynamic Immunotherapies of Cancer

  2023cites this paper
• Effects of HSP70 chaperones Ssa1 and Ssa2 on Ste5 scaffold and the mating mitogen-activated protein kinase (MAPK) pathway in Saccharomyces cerevisiae

  2023cites this paper
• Decoding the roles of heat shock proteins in liver cancer.

  2023cites this paper
• Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture

  2023cites this paper
• Construction of a prognostic model for lung adenocarcinoma based on heat shock protein-related genes and immune analysis

  2023cites this paper
• Preparation of Phage Antibodies to Heat Shock Proteins and Studying the Dynamics of their Accumulation in Mice with Xenotransplant Tumors

  2023cites this paper
• Identification of proteomic biomarkers in proliferative verrucous leukoplakia through LC-MS/MS.

  2023cites this paper
• The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells

  2023cites this paper
• Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes

  2023cites this paper
• A Novel Heat Shock Protein 70-Based Vaccine Prepared from DC Tumor Fusion Cells: An Update.

  2023cites this paper
• The Interplay between T Cells and Cancer: The Basis of Immunotherapy

  2023cites this paper
• Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles

  2023cites this paper
• HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.

  2023cites this paper
• Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics

  2023cites this paper
• Comparing gene expression in deep infiltrating endometriosis with adenomyosis uteri: evidence for dysregulation of oncogene pathways

  2023cites this paper
• A covalent organic framework-based nanoreactor for enhanced photothermal therapy via inhibiting intracellular heat defense systems.

  2023cites this paper
• High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

  2023cites this paper
• An A-ring substituted evodiamine derivative with potent anticancer activity against human non-small cell lung cancer cells by targeting heat shock protein 70.

  2023cites this paper
• Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts—A Systematic Review

  2023cites this paper
• Evaluation of the Anti-Metastatic Effect of Foeniculum Vulgare on the Protein Expression of HSP 70 & 90 in Balb/c Mice with 4t1 Model of Breast Cancer

  2023cites this paper
• The chaperone system in cancer therapies: Hsp90

  2023cites this paper
• Self-Assembly-Based Nanoprobes for the Simultaneous Detection and Downregulation of HSP90α mRNA to Enhance Photothermal Therapy.

  2023cites this paper
• Heat Shock Proteins in Non-Small-Cell Lung Cancer-Functional Mechanism.

  2023cites this paper
• HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer

  2023cites this paper
• TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer

  2023cites this paper
• A Progressively Disassembled DNA Repair Inhibitors Nanosystem for the Treatment of BRCA Wild-Type Triple-Negative Breast Cancer

  2023cites this paper
• Glycolysis inhibition for synergistic phototherapy of triple-negative breast cancer.

  2023cites this paper
• Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence

  2023cites this paper
• HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells

  2023cites this paper
• Cdc37 as a Co-chaperone to Hsp90.

  2023cites this paper
• Hsp70/Hsp90 Organising Protein (Hop): Coordinating Much More than Chaperones.

  2023cites this paper
• HSP70 mediates a crosstalk between the estrogen and the heat shock response pathways

  2023cites this paper
• Implications of Transglutaminase-Mediated Protein Serotonylation in the Epigenetic Landscape, Small Cell Lung Cancer, and Beyond

  2023cites this paper
• Cell-Membrane-Coated and Cell-Penetrating Peptide-Conjugated Trimagnetic Nanoparticles for Targeted Magnetic Hyperthermia of Prostate Cancer Cells

  2023cites this paper
• Tumor-targeting semiconducting polymer nanoparticles: efficient adjuvant photothermal therapy using ultra-low laser power inhibits recurrences after breast-conserving surgery.

  2023cites this paper
• The role of HSP40 in cancer: Recent advances.

  2023cites this paper
• MicroRNA-570 targets the HSP chaperone network, increases proteotoxic stress and inhibits mammary tumor cell migration

  2022cites this paper